The SPRINT trial suggested a more aggressive blood pressure-lowering target reduced the rate of cardiovascular events in hypertensive people, but a new secondary analysis of the trial indicates such an approach may actually be harmful for smokers.

Edwards Lifesciences has invested $35 million for an exclusive right to acquire Corvia Medical, which is engaged in a U.S. pivotal trial for its InterAtrial Shunt Device (IASD) to treat heart failure.

As people around the country struggle to catch up on sleep after “springing forward” an hour, a Washington Post story reminds us of the health risks associated with adjusting our clocks, including an increased incidence of heart attacks.

A smartphone’s camera and flashlight features can detect changes in blood flow and identify type 2 diabetes with accuracy comparable to traditional, clinic-based risk scores, new research suggests.

Both initial and serial increases in high-sensitivity C-reactive protein (hsCRP) concentrations are independently predictive of cardiac events following acute coronary syndrome (ACS), according to a new study in JAMA Cardiology.

The proportion of heart attack patients who are 40 or younger has steadily increased over the last decade, according to research set to be presented March 17 at the American College of Cardiology’s scientific sessions in New Orleans.

To conquer STEMI’s “last frontier,” cardiologists are tapping into an evolving arsenal of strategies while calling for more data and standardized definitions to guide treating physicians.

A new stem cell-based test may add certainty to efforts to predict whether so-called variants of uncertain significance will contribute to the development of diseases or be harmless.